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Clinical Practice Guidelines for Rehab and Oncology
Lehigh Valley Health Network, Allentown, Pennsylvania
Jennifer Roeder, PT, MS;  Stephanie Marshall PT, DPT, OCS; K Leies, RN
As supported by the Center for Disease Control, there is a National 
Action Plan for Cancer Survivorship.  Some of those Action Plan 
initiatives include Education. Health care provider training aims to 
ensure that providers are aware of the medical and other special needs 
of cancer survivors so they can offer the spectrum of services available 
to enhance quality of life throughout survivorship and refer survivors to 
these services as appropriate. 
Evaluation:
Disease Management Groups review and update all guidelines on an 
annual basis. Rehabilitation will evaluate referral patterns and patient 
satisfaction as initial quality measures. The Nurse Coordinator will 
develop outcome measurement tools to augment the quality process.
Discussion:
Expanding our Clinical Practice Guidelines from a traditional physician 
focus has provided an educational experience for our entire oncology 
team. Providers demonstrate a heightened commitment to guideline 
development and outcome evaluation.  Nursing leadership has utilized 
a strong evidence-based format to enhance the delivery of cancer care 
at Lehigh Valley Health Network.
Introduction/Purpose:
Patients have a right to expect that treatment recommendations reflect 
not only national consensus, but also are evidence based and cost 
effective in their approach. The disease management team will adopt 
the NCCN guidelines as a model for the development of guidelines 
of care; and examine, as data is available, the costs associated with 
these guidelines at Lehigh Valley Health Network, the development of 
efficient pathways to minimize the cost and maintain quality outcomes.
Scope:
These clinical practice guidelines will apply to all physicians, nurse 
practitioners, and physician assistants who provide treatment to adult 
patients with the diagnosis of a cancer.
Interventions:
A multidisciplinary team of Rehabilitation Program professionals 
developed an evidence-based algorithm to identify immediate and 
long-term physical sequelae resulting from disease or treatment. 
Predisposing factors, descriptions of interventions and notation of 
appropriate consult targets were also included. A nurse led work-
group added information to the predisposing factors, such as specific 
agents contributing to the late effects of chemotherapy. We presented 
the information to the disease management team for review and 
incorporation into the Central Nervous System Guidelines. The design 
of this initial algorithm will serve as a template for additional ancillary 
care protocols such as survivorship. Our guidelines can be easily be 




Factors PT OT SLP AUD CR PR
Description of
Intervention




RT brain edema X X
OT and speech assessment and 
teatment.
Vocal cord paralysis, speech 




RT to salivary gland area X
Speech, cognitive and swallowing 
assessment and treatment




X Postural correction, abdominal and 
core muscle strengthening
Myopathy, impaired muscle 





Ambulation needs; functional motion 
for ADL needs; core strength/
supporting trunk musculature for 
quality of movement; fine motor 
coordination issues




treatment-related fatigue X X
PT for exercise and conditioning for 
cancer realted fatigue
OT for energy conservation strategies






Audiology and VNG 
(videonystagmography)
PT calance/vestibular specialists
Impaired motor function & 
sensory integrity associated with 
polyneuropathy (Post-surgical 






PT for skin inspection, protection, 
weakness, foot drop, gait disturbance
OT for sensory loss compensation, 
fine motor coordination issues
Avascular necrosis-acute (2,10,18) Steroid therapy (within a 
few weeks of starting) X
PT assessment and treatment for 






X Education in weight bearing exercise & strengthening
Proximal muscle weakness and 
eventual muscle wasting, primarily 




PT or core strengthening; postural 
muscle endurance; pelvic 
floor specialists; OT for energy 
conservatin; ADL retraining
Cardiac complications related to late 
effects chemotherapy (1,2,5,9,10,19) X
CR to promote endurance
Pulmonary complications related 
to late effects of chemotherapy 
(1,2,4,5,10)
Carmustine/BCNU
Total steroid dose X X
PR to improve conditioning 
OT for energy conservation and ADL 
retraining
Cancer related pain 
(1,2,8,9,10,12,16,24) X X
Pain management with non-
pharmacologic modalities
Late effect avascular necrosis (18) Steroid therapy (within a 
few weeks of starting) X
PT assessment and treatment for 
gait; safety pending orthopedic 
follow-up
Figure 1.  Relative Survival by Survival Time by Cancer Site
All Ages, All Races, Both Sexes
1988-2006
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OT = Occupational Therapy
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AUD = Audiology
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Cancer sites include invasive cases only unless otherwise noted.
Survival source: SEER 9 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, 
and Atlanta).
The annual survival estimates are calculated using monthly intervals.
